Gabapentin and dementia
Pro Research Analysisby 
Searched over 200M research papers
Gabapentin and Dementia: A Comprehensive Review
Gabapentin for Behavioral and Psychological Symptoms of Dementia (BPSD)
Efficacy and Safety Profile
Gabapentin, an antiepileptic agent, is increasingly considered for treating behavioral and psychological symptoms of dementia (BPSD) due to its favorable safety profile compared to other psychiatric medications. Several case reports, case series, and a retrospective chart review suggest that gabapentin is well-tolerated and effective in managing BPSD in most cases 134. However, its appropriateness for all types of dementia-related agitation, such as in dementia with Lewy bodies, remains questionable .
Clinical Studies and Observations
In a study involving 20 patients with probable Alzheimer’s disease and serious comorbidities, gabapentin was found to be efficacious and well-tolerated over a 15-month period, reducing caregiver stress and showing no significant drug interactions . Another retrospective chart review of 24 patients with dementia indicated that gabapentin significantly improved aggressive and agitated behaviors, with minimal side effects reported . Additionally, a small case series demonstrated that low-dose gabapentin effectively managed aggressive behavior in patients with vascular or mixed vascular/Alzheimer dementia without adverse reactions .
Gabapentin and Risk of Dementia
Cognitive Decline and Dementia Risk
While gabapentin is used to manage BPSD, its association with cognitive decline and increased dementia risk has raised concerns. A large population-based study in Taiwan found that gabapentin or pregabalin use was associated with a higher risk of developing dementia, with the risk increasing with higher cumulative doses . This association was significant across all age groups but was notably higher in younger patients under 50 years old .
Neurocognitive Changes in Older Adults
A retrospective cohort study examining older adults with initially normal cognition revealed that gabapentin initiation was significantly associated with cognitive and functional status decline, as well as increased falls . These findings underscore the need for caution when prescribing gabapentin to older adults, particularly those with normal cognitive function at baseline.
Utilization Trends and Concurrent Medication Use
Trends in Gabapentin Use
Data from the National Alzheimer's Coordinating Center (2006-2019) showed an increase in gabapentin use among older adults with varying cognitive statuses, including those with dementia . The study also highlighted the frequent concurrent use of gabapentin with potentially inappropriate medications such as opioids, benzodiazepines, antidepressants, and antipsychotics, especially in patients with dementia .
Conclusion
Gabapentin shows promise in managing behavioral and psychological symptoms of dementia, particularly in patients with comorbidities where other psychotropic drugs may be contraindicated. However, its use is not without risks, as it has been associated with cognitive decline and an increased risk of dementia. The growing trend of gabapentin use among older adults, often in combination with other medications, calls for rigorous studies to further examine its safety and efficacy in this vulnerable population. Controlled studies are essential to establish clear guidelines for the clinical use of gabapentin in treating BPSD.
Sources and full results
Most relevant research papers on this topic
Use of Gabapentin in the Treatment of Behavioural and Psychological Symptoms of Dementia
Gabapentin shows potential as a well-tolerated and effective treatment for behavioral and psychological symptoms of dementia, but more controlled studies are needed for clinical indication.
The association between Gabapentin or Pregabalin use and the risk of dementia: an analysis of the National Health Insurance Research Database in Taiwan
Gabapentin or pregabalin use is associated with an increased risk of dementia, particularly in younger patients.
A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.
Gabapentin effectively reduces aggressive and agitated behaviors in nursing home patients with dementia, with no significant side effects observed in up to 2 years of treatment.
DOI